Correction: Exosomes derived from burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells (The Journal of Immunology (2014) 192 (5852–5862) DOI: 10.4049/jimmunol.1302068);Exosomes derived from Burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 5852-5862

  Gutzeit, Cindy ^a,d   Nagy, Noemi ^b   Gentile, Maurizio ^c   Lyberg, Katarina ^a   Gumz, Janine ^a   Vallhov, Helen ^a   Puga, Irene ^c   Klein, Eva ^b   Gabrielsson, Susanne ^a   Cerutti, Andrea ^c   Scheynius, Annika ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CD19 ANTIGEN; CD20 ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G1;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; EPSTEIN BARR VIRUS; EXOSOME; GENE SWITCHING; HUMAN; HUMAN CELL; INTERNALIZATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR DYNAMICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; EXOSOMES; FEMALE; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; MALE; VIRAL MATRIX PROTEINS;

EID: 84902186661     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1900638     Document Type: Erratum

References (51)

1. Bobrie, A., M. Colombo, G. Raposo, and C. Théry. 2011. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12:1659-1668.
2. Mathivanan, S., H. Ji, and R. J. Simpson. 2010. Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73:1907-1920.
3. Théry, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9:581-593.
4. McLellan, A. D. 2009. Exosome release by primary B cells. Crit. Rev. Immunol. 29:203-217.
5. Chaput, N., and C. Théry. 2011. Exosomes: immune properties and potential clinical implementations. Semin. Immunopathol. 33:419-440.
6. Taylor, D. D., S. Akyol, and C. Gercel-Taylor. 2006. Pregnancy-associated exosomes and their modulation of T cell signaling. J. Immunol. 176:1534-1542.
7. Admyre, C., S. M. Johansson, K. R. Qazi, J. J. Filén, R. Lahesmaa, M. Norman, E. P. Neve, A. Scheynius, and S. Gabrielsson. 2007. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 179:1969-1978.
8. Théry, C., L. Duban, E. Segura, P. Véron, O. Lantz, and S. Amigorena. 2002. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3:1156-1162.
9. Klein, G., E. Klein, and E. Kashuba. 2010. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Biochem. Biophys. Res. Commun. 396:67-73.
10. Chaganti, S., C. S. Ma, A. I. Bell, D. Croom-Carter, A. D. Hislop, S. G. Tangye, and A. B. Rickinson. 2008. Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients. Blood 112:672-679.
11. Chaganti, S., E. M. Heath, W. Bergler, M. Kuo, M. Buettner, G. Niedobitek, A. B. Rickinson, and A. I. Bell. 2009. Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence. Blood 113:6372-6381.
12. Küppers, R. 2003. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3:801-812.
13. Niller, H. H., H. Wolf, and J. Minarovits. 2008. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 41:298-328.
14. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Liejendekker, C. V. Harding, C. J. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161-1172.
15. Flanagan, J., J. Middeldorp, and T. Sculley. 2003. Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J. Gen. Virol. 84:1871-1879.
16. Middeldorp, J. M., and D. M. Pegtel. 2008. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin. Cancer Biol. 18:388-396.
17. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. Van Arsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
18. Verweij, F. J., M. A. Van Eijndhoven, E. S. Hopmans, T. Vendrig, T. Wurdinger, E. Cahir-McFarland, E. Kieff, D. Geerts, R. Van Der Kant, J. Neefjes, et al. 2011. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation. EMBO J. 30:2115-2129.
19. Dukers, D. F., P. Meij, M. B. Vervoort, W. Vos, R. J. Scheper, C. J. Meijer, E. Bloemena, and J. M. Middeldorp. 2000. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 165:663-670.
20. Keryer-Bibens, C., C. Pioche-Durieu, C. Villemant, S. Souquère, N. Nishi, M. Hirashima, J. Middeldorp, and P. Busson. 2006. Exosomes released by EBVinfected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 6:283.
21. Qazi, K. R., U. Gehrmann, E. Domange Jordö, M. C. Karlsson, and S. Gabrielsson. 2009. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood 113:2673-2683.
22. Ben-Bassat, H., N. Goldblum, S. Mitrani, T. Goldblum, J. M. Yoffey, M. M. Cohen, Z. Bentwich, B. Ramot, E. Klein, and G. Klein. 1977. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D. G.-75). Int. J. Cancer 19:27-33.
23. Cuomo, L., P. Trivedi, F. Wang, G. Winberg, G. Klein, and M. G. Masucci. 1990. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Eur. J. Immunol. 20:2293-2299.
24. Maeda, A., C. Kiss, F. Chen, B. Ehlin-Henriksson, N. Nagy, L. Szekely, K. Takada, E. Klein, and G. Klein. 2001. EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain. Int. J. Cancer 93:714-719.
25. Vallhov, H., C. Gutzeit, S. M. Johansson, N. Nagy, M. Paul, Q. Li, S. Friend, T. C. George, E. Klein, A. Scheynius, and S. Gabrielsson. 2011. Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J. Immunol. 186:73-82.
26. He, B., R. Santamaria, W. Xu, M. Cols, K. Chen, I. Puga, M. Shan, H. Xiong, J. B. Bussel, A. Chiu, et al. 2010. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat. Immunol. 11:836-845.
27. He, B., N. Raab-Traub, P. Casali, and A. Cerutti. 2003. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cellindependent Ig heavy chain class switching. J. Immunol. 171:5215-5224.
28. Yang, X., Z. He, B. Xin, and L. Cao. 2000. LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression. Oncogene 19:2002-2013.
29. Pegtel, D. M., K. Cosmopoulos, D. A. Thorley-Lawson, M. A. Van Eijndhoven, E. S. Hopmans, J. L. Lindenberg, T. D. De Gruijl, T. Würdinger, and J. M. Middeldorp. 2010. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. USA 107:6328-6333.
30. McHeyzer-Williams, M., S. Okitsu, N. Wang, and L. McHeyzer-Williams. 2012. Molecular programming of B cell memory. Nat. Rev. Immunol. 12:24-34.
31. Kinoshita, K., M. Harigai, S. Fagarasan, M. Muramatsu, and T. Honjo. 2001. A hallmark of active class switch recombination: transcripts directed by I promoters on looped-out circular DNAs. Proc. Natl. Acad. Sci. USA 98:12620-12623.
32. Saunderson, S. C., P. C. Schuberth, A. C. Dunn, L. Miller, B. D. Hock, P. A. MacKay, N. Koch, R. W. Jack, and A. D. McLellan. 2008. Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor. J. Immunol. 180:8146-8152.
33. Rowe, M., R. Khanna, C. A. Jacob, V. Argaet, A. Kelly, S. Powis, M. Belich, D. Croom-Carter, S. Lee, S. R. Burrows, et al. 1995. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLAclass I antigen expression. Eur. J. Immunol. 25:1374-1384.
34. Zhang, Q., L. Brooks, P. Busson, F. Wang, D. Charron, E. Kieff, A. B. Rickinson, and T. Tursz. 1994. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line. Eur. J. Immunol. 24:1467-1470.
35. Raposo, G., and W. Stoorvogel. 2013. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200:373-383.
36. Montecalvo, A., A. T. Larregina, W. J. Shufesky, D. B. Stolz, M. L. Sullivan, J. M. Karlsson, C. J. Baty, G. A. Gibson, G. Erdos, Z. Wang, et al. 2012. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119:756-766.
37. Mehta, D. S., A. L. Wurster, M. J. Whitters, D. A. Young, M. Collins, and M. J. Grusby. 2003. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170:4111-4118.
38. Schweighoffer, E., L. Vanes, J. Nys, D. Cantrell, S. McCleary, N. Smithers, and V. L. Tybulewicz. 2013. The BAFF receptor transduces survival signals by coopting the B cell receptor signaling pathway. Immunity 38:475-488.
39. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20:785-798.
40. Thornburg, N. J., W. Kulwichit, R. H. Edwards, K. H. Shair, K. M. Bendt, and N. Raab-Traub. 2006. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25:288-297.
41. Kilger, E., A. Kieser, M. Baumann, and W. Hammerschmidt. 1998. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17:1700-1709.
42. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340:393-397.
43. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
44. Klein, U., K. Rajewsky, and R. Küppers. 1998. Human immunoglobulin (Ig) M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679-1689.
45. Weller, S., M. C. Braun, B. K. Tan, A. Rosenwald, C. Cordier, M. E. Conley, A. Plebani, D. S. Kumararatne, D. Bonnet, O. Tournilhac, et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104:3647-3654.
46. Werner-Favre, C., F. Bovia, P. Schneider, N. Holler, M. Barnet, V. Kindler, J. Tschopp, and R. H. Zubler. 2001. IgG subclass switch capacity is low in switched and in IgM-only, but high in IgD+IgM+, post-germinal center (CD27+) human B cells. Eur. J. Immunol. 31:243-249.
47. Xu, Z., H. Zan, E. J. Pone, T. Mai, and P. Casali. 2012. Immunoglobulin classswitch DNA recombination: induction, targeting and beyond. Nat. Rev. Immunol. 12:517-531.
48. Pone, E. J., J. Zhang, T. Mai, C. A. White, G. Li, J. K. Sakakura, P. J. Patel, A. Al-Qahtani, H. Zan, Z. Xu, and P. Casali. 2012. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway. Nat. Commun. 3:767.
49. Rawlings, D. J., M. A. Schwartz, S. W. Jackson, and A. Meyer-Bahlburg. 2012. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 12:282-294.
50. Stavnezer, J., J. E. Guikema, and C. E. Schrader. 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26:261-292.
51. Pène, J., J. F. Gauchat, S. Lécart, E. Drouet, P. Guglielmi, V. Boulay, A. Delwail, D. Foster, J. C. Lecron, and H. Yssel. 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172:5154-5157